Answers are grounded in this paper and cite their sources.
The antibacterial activity of LY146032 alone and in combination with other drugs was assayed against gram-positive isolates. Synergism was found when LY146032 was combined with netilmicin, amikacin, imipenem, and fosfomycin by both checkerboard and time-kill tests. Indifference predominated when LY146032 was combined with teicoplanin, vancomycin, and rifampin. Under no circumstances and with no combinations was an antagonistic effect detected.
No takes yet. Share an insight, caveat, or question.
Debbia et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: